H. Schäfer

Guidance for handling and use of nanomaterials at the workplace

M. Heinemann, H. Schäfer, M Heinemann, 2009, Human & experimental toxicology.

Biosimulation in Clinical Drug Development

Thorsten Lehr, Alexander Staab, T. Lehr, 2008 .

Population Pharmacokinetic Analysis of the New Oral Thrombin Inhibitor Dabigatran Etexilate (BIBR 1048) in Patients Undergoing Primary Elective Total Hip Replacement Surgery

I. Trocóniz, C. Tillmann, J. Stangier, 2007, Journal of clinical pharmacology.

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.

B. Eriksson, I. Trocóniz, C. Tillmann, 2006, British journal of clinical pharmacology.

Joint Population Pharmacokinetic/Pharmacodynamic Model for the Heart Rate Effects at Rest and at the End of Exercise for Cilobradine

N. Vélez de Mendizábal, I. Trocóniz, D. Trommeshauser, 2013, Pharmaceutical Research.

Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladder.

S. Higuchi, A. Sarashina, I. Ieiri, 2010, British journal of clinical pharmacology.